SCHEMBL2401696

SCHEMBL2401696

CC(C)N1CCN(C(=O)[C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
HRH3 Q9Y5N1 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 2/20 0.47
RORC P51449 1/20 0.47
HTR1A P08908 5/20 0.46
HTR7 P34969 5/20 0.46
DRD2 P14416 2/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
MMP2 P08253 1/20 0.45
MMP13 P45452 1/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401700 1.00 L3MBTL1 (0.50) L3MBTL1HRH3MEN1KMT2AALDH1A1
SCHEMBL2400299 0.90 MEN1 (0.50) HRH3MEN1KMT2AALDH1A1DRD2
SCHEMBL2400297 0.90 MEN1 (0.50) HRH3MEN1KMT2AALDH1A1DRD2
SCHEMBL2402023 0.89 CNR1 (0.55) HRH3MEN1KMT2AALDH1A1MMP2
SCHEMBL2402029 0.89 CNR1 (0.55) HRH3MEN1KMT2AALDH1A1MMP2
SCHEMBL2404229 0.88 KMT2A (0.58) L3MBTL1HRH3MEN1KMT2AALDH1A1
SCHEMBL2404388 0.88 KMT2A (0.58) L3MBTL1HRH3MEN1KMT2AALDH1A1
SCHEMBL2401335 0.88 EPHX2 (0.49) HRH3MEN1KMT2AALDH1A1MMP2
SCHEMBL2404226 0.88 KMT2A (0.58) L3MBTL1HRH3MEN1KMT2AALDH1A1
SCHEMBL2946427 0.88 EPHX2 (0.49) HRH3MEN1KMT2AALDH1A1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 L3MBTL1 3656/4885HRH3 1/4885MEN1 3462/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 L3MBTL1 3656/4885HRH3 1/4885MEN1 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.